Similar articles for PMID: 12208422

Year	Number of Results
1996	1
1998	1
1999	4
2000	10
2001	2
2002	4
2003	10
2004	7
2005	3
2006	4
2007	3
2008	1
2009	3
2010	3
2011	2
2012	6
2013	3
2014	2
2015	3
2016	6
2017	2
2018	1
2020	2
2022	1
2024	0

1

Association of the G20210A mutation in the factor II gene with systemic embolism in nonvalvular atrial fibrillation.

Pengo V, Filippi B, Biasiolo A, Pegoraro C, Noventa F, Iliceto S. Pengo V, et al. Am J Cardiol. 2002 Sep 1;90(5):545-7. doi: 10.1016/s0002-9149(02)02534-1. Am J Cardiol. 2002. PMID: 12208422 No abstract available.

2

The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation.

Berge E, Haug KB, Sandset EC, Haugbro KK, Turkovic M, Sandset PM. Berge E, et al. Stroke. 2007 Mar;38(3):1069-71. doi: 10.1161/01.STR.0000258076.04860.8e. Epub 2007 Feb 8. Stroke. 2007. PMID: 17290027

3

Prothrombin G20210A and factor V Leiden polymorphisms in stroke.

They-They TP, Battas O, Slassi I, Rafai MA, Katumbay DT, Nadifi S. They-They TP, et al. J Mol Neurosci. 2012 Jan;46(1):210-6. doi: 10.1007/s12031-011-9580-9. Epub 2011 Jun 24. J Mol Neurosci. 2012. PMID: 21701789

4

Prevalence of prothrombin G20210A mutation in patients with atrial fibrillation: A systematic review and meta-analysis.

Gandara E, Barboza AG, Vazquez F. Gandara E, et al. Thromb Res. 2016 Nov;147:7-9. doi: 10.1016/j.thromres.2016.09.012. Epub 2016 Sep 15. Thromb Res. 2016. PMID: 27664389 Review. No abstract available.

5

Thrombophilic mutations in high-risk atrial fibrillation patients: high prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism.

Poli D, Antonucci E, Cecchi E, Betti I, Valdrè L, Mugnaini C, Alterini B, Morettini A, Nozzoli C, Abbate R, Gensini GF, Prisco D. Poli D, et al. Thromb Haemost. 2003 Dec;90(6):1158-62. doi: 10.1160/TH03-04-0240. Thromb Haemost. 2003. PMID: 14652651

6

[Predictors of intracardiac thrombosis in patients with atrial fibrillation: factors of hemostasis, markers of inflammation, and genetic factors].

Zotova IV, Zateĭshchikov DA, Sidorenko BA. Zotova IV, et al. Kardiologiia. 2007;47(11):46-54. Kardiologiia. 2007. PMID: 18260964 Review. Russian.

7

Does activated protein C resistance increase the risk of systematic embolism in non rheumatic atrial fibrillation?

Eikelboom J, Thom J, Van Bockxmeer F, Baker R. Eikelboom J, et al. Aust N Z J Med. 1996 Apr;26(2):243-4. doi: 10.1111/j.1445-5994.1996.tb00899.x. Aust N Z J Med. 1996. PMID: 8744632 No abstract available.

8

Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.

Karttunen V, Hiltunen L, Rasi V, Vahtera E, Hillbom M. Karttunen V, et al. Blood Coagul Fibrinolysis. 2003 Apr;14(3):261-8. doi: 10.1097/01.mbc.0000061288.28953.c8. Blood Coagul Fibrinolysis. 2003. PMID: 12695749

9

Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia.

Lichy C, Reuner KH, Buggle F, Litfin F, Rickmann H, Kunze A, Brandt T, Grau A. Lichy C, et al. Cerebrovasc Dis. 2003;16(1):83-7. doi: 10.1159/000070120. Cerebrovasc Dis. 2003. PMID: 12766367 Clinical Trial.

10

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.

Piccini JP, Stevens SR, Chang Y, Singer DE, Lokhnygina Y, Go AS, Patel MR, Mahaffey KW, Halperin JL, Breithardt G, Hankey GJ, Hacke W, Becker RC, Nessel CC, Fox KA, Califf RM; ROCKET AF Steering Committee and Investigators. Piccini JP, et al. Circulation. 2013 Jan 15;127(2):224-32. doi: 10.1161/CIRCULATIONAHA.112.107128. Epub 2012 Dec 3. Circulation. 2013. PMID: 23212720 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

76 results

Results by year